43742-1506 NDC - RAGE (APIS MELLIFICA, CANTHARIS, CHAMOMILLA, ADRENALINUM, CEREBRUM SUIS, HYPOPHYSIS SUIS, ACONITUM NAPELLUS, AGARICUS MUSCARIUS, ATROPINUM, CAUSTICUM, CICUTA VIROSA, CUPRUM METALLICUM, HYOSCYAMUS NIGER, LAC CANINUM, MOSCHUS, STRAMONIUM, TARENTULA HISPANA, VERATRUM ALBUM, HOMARUS, CAMPHORA)

Drug Information

  • Product NDC: 43742-1506
  • Proprietary Name: Rage
  • Non Proprietary Name: Apis Mellifica, Cantharis, Chamomilla, Adrenalinum, Cerebrum Suis, Hypophysis Suis, Aconitum Napellus, Agaricus Muscarius, Atropinum, Causticum, Cicuta Virosa, Cuprum Metallicum, Hyoscyamus Niger, Lac Caninum, Moschus, Stramonium, Tarentula Hispana, Veratrum Album, Homarus, Camphora
  • Active Ingredient(s): 12 [hp_X]/mL ACONITUM NAPELLUS WHOLE; 12 [hp_X]/mL AMANITA MUSCARIA FRUITING BODY; 6 [hp_X]/mL APIS MELLIFERA; 12 [hp_X]/mL ATROPINE; 30 [hp_X]/mL CAMPHOR (NATURAL); 12 [hp_X]/mL CANIS LUPUS FAMILIARIS MILK; 12 [hp_X]/mL CAUSTICUM; 12 [hp_X]/mL CICUTA VIROSA ROOT; 12 [hp_X]/mL COPPER; 12 [hp_X]/mL DATURA STRAMONIUM; 8 [hp_X]/mL EPINEPHRINE; 17 [hp_X]/mL HOMARUS AMERICANUS DIGESTIVE FLUID; 12 [hp_X]/mL HYOSCYAMUS NIGER; 12 [hp_X]/mL LYCOSA TARANTULA; 6 [hp_X]/mL LYTTA VESICATORIA; 6 [hp_X]/mL MATRICARIA CHAMOMILLA WHOLE; 12 [hp_X]/mL MOSCHUS MOSCHIFERUS MUSK SAC RESIN; 8 [hp_X]/mL SUS SCROFA CEREBRUM; 8 [hp_X]/mL SUS SCROFA PITUITARY GLAND; 12 [hp_X]/mL VERATRUM ALBUM ROOT
  • Administration Route(s): ORAL
  • Dosage Form(s): LIQUID
  • Pharmacy Class(es): Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Anticholinergic [EPC]; Bee Venoms [CS]; Catecholamine [EPC]; Catecholamines [CS]; Cell-mediated Immunity [PE]; Cholinergic Antagonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]; Copper [CS]; Copper-containing Intrauterine Device [EPC]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Inhibit Ovum Fertilization [PE]; Standardized Insect Venom Allergenic Extract [EPC]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]

Labeler Information

Field Name Field Value
Labeler Name: Deseret Biologicals, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:7/25/2019
End Marketing Date:11/30/2028

Package Information

No. Package Code Package Description Billing Unit
143742-1506-130 mL in 1 BOTTLE, DROPPER (43742-1506-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC43742-1506The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMERageThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEApis Mellifica, Cantharis, Chamomilla, Adrenalinum, Cerebrum Suis, Hypophysis Suis, Aconitum Napellus, Agaricus Muscarius, Atropinum, Causticum, Cicuta Virosa, Cuprum Metallicum, Hyoscyamus Niger, Lac Caninum, Moschus, Stramonium, Tarentula Hispana, Veratrum Album, Homarus, CamphoraThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE7/25/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE11/30/2028This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEDeseret Biologicals, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEACONITUM NAPELLUS WHOLE; AMANITA MUSCARIA FRUITING BODY; APIS MELLIFERA; ATROPINE; CAMPHOR (NATURAL); CANIS LUPUS FAMILIARIS MILK; CAUSTICUM; CICUTA VIROSA ROOT; COPPER; DATURA STRAMONIUM; EPINEPHRINE; HOMARUS AMERICANUS DIGESTIVE FLUID; HYOSCYAMUS NIGER; LYCOSA TARANTULA; LYTTA VESICATORIA; MATRICARIA CHAMOMILLA WHOLE; MOSCHUS MOSCHIFERUS MUSK SAC RESIN; SUS SCROFA CEREBRUM; SUS SCROFA PITUITARY GLAND; VERATRUM ALBUM ROOTAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH12; 12; 6; 12; 30; 12; 12; 12; 12; 12; 8; 17; 12; 12; 6; 6; 12; 8; 8; 12 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAdrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Anticholinergic [EPC], Bee Venoms [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Inhibit Ovum Fertilization [PE], Standardized Insect Venom Allergenic Extract [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 6/6/2025

Previous Code
Next Code